Results 181 to 190 of about 29,778 (296)

Beyond Traditional Screening: The Future of Heart Failure Detection With Biomarkers and AI

iNew Medicine, EarlyView.
Advancing HF Screening: Integrating Technology and Risk Factors Across Eras. This diagram provides a comprehensive review of the historical developments and projected trends of heart failure (HF) screening methodologies, with the prevalent risk factors for HF depicted at the base.
Xiaofeng Fang, Yinbo Xu, Yiting Zhao, Liuyi Li, Zhengyi Cheng, Zhongqi Zhang, Yuhang Luo, Qiaoling Liu, Chen Gong, Shichun Shen   +9 more
wiley   +1 more source

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

The Effects of Angiotensin Receptor Neprilysin Inhibitor on Endoplasmic Reticulum Stress in Doxorubicin‐Mediated Cardiomyopathy‐Associated Heart Failure Model in Rats

Journal of Applied Toxicology, EarlyView.
ABSTRACT One of the most serious complications associated with the use of the chemotherapeutic agent doxorubicin (DOX) is cardiomyopathy. Although cardioprotective drugs such as angiotensin receptor‐neprilysin inhibitors (ARNI) are used to prevent cardiomyopathy in DOX patients, no studies have reported the relationship between ARNI and endoplasmic ...
Mert Unvan, Meryem İlkay Karagül, Hatice Oruç Demirbağ, Ebru Balli   +3 more
wiley   +1 more source

Natriuretic peptides testing and survival prediction models for chronic heart failure: a systematic review of added prognostic value. [PDF]

Diagn Progn Res
Smith CA, Taylor KS, Jones NR, Roth D, Magona A, Roberts N, Taylor CJ, Hobbs FDR, Vazquez-Montes MDLA.   +8 more
europepmc   +1 more source

Analytical and Workflow Performance of a High‐Throughput Chemiluminescent Immunoassay System in a Clinical Laboratory

Journal of Clinical Laboratory Analysis, EarlyView.
Analytical and operational performance evaluation of the DxI 9000 Access Immunoassay Analyzer in a clinical laboratory in Taiwan. ABSTRACT Background Increasing test volumes and shorter turnaround time (TAT) requirements, particularly in acute‐care settings, challenge clinical laboratories to maintain accurate immunoassay testing.
Chiung‐Tzu Hsiao, Chao‐Ching Liao, Yu‐Chang Chang, Hui‐Ju Chang, Tz‐Ya Huang, Jen‐Shiou Lin, Po‐Ren Hsueh   +6 more
wiley   +1 more source

Machine learning to optimize use of natriuretic peptides in the diagnosis of acute heart failure. [PDF]

Eur Heart J Acute Cardiovasc Care
Doudesis D, Lee KK, Anwar M, Singer AJ, Hollander JE, Chenevier-Gobeaux C, Claessens YE, Wussler D, Weil D, Kozhuharov N, Strebel I, Sabti Z, deFilippi C, Seliger S, Mesquita ET, Wiemer JC, Möckel M, Coste J, Jourdain P, Kimiaki K, Yoshimura M, Ibrahim I, Ooi SBS, Kuan WS, Gegenhuber A, Mueller T, Hanon O, Vidal JS, Cameron P, Lam L, Freedman B, Chung T, Collins SP, Lindsell CJ, Newby DE, Japp AG, Shah ASV, Villacorta H, Richards AM, McMurray JJV, Mueller C, Januzzi JL, Mills NL, CoDE-HF investigators .   +43 more
europepmc   +1 more source

Extreme Heterophilic Antibody Interference in BNP Immunoassay: A Case Report and Systematic Investigation Protocol

Journal of Clinical Laboratory Analysis, EarlyView.
A 53 year‐old male with type 2 diabetes presented extremely elevated BNP (> 4000 pg/mL) but normal NT‐proBNP and cardiac function. Systematic verification confirmed severe heterophilic antibody (HAMA) interference in the BNP chemiluminescence immunoassay.
Huicong Yang, Yuanhai Zheng, Zhenhua Zeng, Haimin Gao, Jinzhi Wu, Ayang Wu, Jie Lin   +6 more
wiley   +1 more source

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex. [PDF]

JACC Adv
Bobrowski D, Abdel-Qadir H, McNaughton CD, Chu A, Wang X, Austin PC, Doumouras BS, Abdul-Samad K, Kavsak PA, Farkouh ME, Januzzi JL, Ross HJ, Lee DS.   +12 more
europepmc   +1 more source

Natriuretic Peptides and Need for Reliable Tool to Assess Pulmonary Congestion for Treatment Monitoring in Heart Failure. [PDF]

J Community Hosp Intern Med Perspect, 2023
Bhatia MS, Attri R, Sharda SC, Swarup P, Garg A.   +4 more
europepmc   +1 more source

Asymptomatic Giant Right Ventricular Myxoma in an Adolescent: A Rare Case Report With Favorable Surgical Outcome

Journal of Clinical Ultrasound, EarlyView.
We report a 13‐year‐old female with a giant right ventricular myxoma extending to the pulmonary trunk. The tumor was diagnosed by multimodal imaging and completely resected, with favorable short‐term outcomes. ABSTRACT Right ventricular (RV) myxomas account for < 5% of cardiac myxomas and are often asymptomatic, easily overlooked.
Aizezi Maihemu, Jin Bai, Chongjun Qi, Jian Liu   +3 more
wiley   +1 more source